Arline Kaplan

WALGREENS PHARMACY #4266

10510 E GEYER WILLOW RD

Articles

Creativity and Mental Illness

April 17, 2014

Since the terms “genius” and “creativity” have different definitions, Psychiatric Times asked a neuropsychologist and creativity expert to clarify how the terms are being used in scientific studies.

Benzodiazepines vs Antidepressants for Anxiety Disorders

December 19, 2013

A recent systematic review and meta-analysis that compared benzodiazepines with antidepressants for anxiety disorders has triggered a debate among clinicians about first-line treatments, efficacy for specific disorders, and adverse effects.

Psychiatric Drug Pipeline

October 08, 2013

Despite pharma's retreat and the many challenges in psychiatric drug development -- as detailed here -- the current psychiatric drug pipeline is not totally dry.

Mind-Body Interventions for Mood Disorders in Older Adults

September 09, 2013

Nonpharmacological interventions-such as mind-body interventions-can improve a partial response to antidepressants via stress reduction, improved physical functioning, increased socialization, and reduced risks of polypharmacy.

Catching Up on Sleep: From Comorbidity to Pharmacotherapy

August 26, 2013

More than half of all patients with psychiatric disorders report disturbances of sleep and wakefulness. "Sleep disorders are associated with impaired daytime function and predict a heightened future vulnerability to psychiatric disease. They also diminish life span.” Details from an expert here.

Lithium’s Neuroprotective Effects

August 21, 2013

While the growing evidence base for the positive effects of lithium on brain health is compelling, the evidence remains preliminary.